vintage leather messenger large hide soft luggage travel bag backpack briefcase Men's Bags


  1. Home
  2. vintage leather messenger large hide soft luggage travel bag backpack briefcase
  1. facebook
  2. twitter
  3. linkedin
  4. pinterest
vintage leather messenger large hide soft luggage travel bag backpack briefcase
Condition: New without tags: A brand-new, unused, and unworn item (including handmade items) that is not in original packaging or Size: Large
MPN:

Does not apply

Colour: Brown
Hard/Soft: Soft Style: Messenger/Shoulder Bag
Brand:

Unbranded

Material: Leather
Product Type: Bags, Briefcases Features: Adjustable Strap, Eco-Friendly, Expandable, Key Clip
UPC:

Does not apply







published on tue nov 09 2021

vintage leather messenger large hide soft luggage travel bag backpack briefcase Men's Bags

gandhi, s., klein, j., robertson, a., pena-hernandez, m. a.,

vintage leather messenger large hide soft luggage travel bag backpack briefcase Men's Bags

lin, m. j., roychoudhury, p., lu, p., fournier, j., ferguson, d., mohamed bakhash, s. a., muenker, m. c., srivathsan, a., wunder, e. a., kerantzas, n., wang, w., pyle, a., wilen, c. b., ogbuagu, o., greninger ,, a. l., iwasaki, a., schulz, w. l., ko, a. i.

sars-cov-2 remdesivir resistance mutations have been generated in vitro but have not been reported in patients receiving treatment with the antiviral agent. we present a case of an immunocompromised patient with acquired b-cell deficiency who developed an indolent, protracted course of sars-cov-2 infection. remdesivir therapy alleviated symptoms and produced a transient virologic response, but her course was complicated by recrudescence of high-grade viral shedding. whole genome sequencing identified a mutation, e802d, in the nsp12 rna-dependent rna polymerase which was not present in pre-treatment specimens. in vitro experiments demonstrated that the mutation conferred a ~6-fold increase in remdesivir ic50 but resulted in a fitness cost in the absence of remdesivir. sustained clinical and virologic response was achieved after treatment with casirivimab-imdevimab. although the fitness cost observed in vitro may limit the risk posed by e802d,

, this case illustrates the importance of monitoring for remdesivir resistance and the potential benefit of combinatorial therapies in immunocompromised patients with sars-cov-2 infection.

509
1.2k
EVGENIA.RU RSS